ETON vs ROP · rev $39.0M vs P/E 41, rev $1.88B
Eton Pharmaceuticals Inc (ETON) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported ETON revenue for 2024-12-31 was $39.0M. Net income was -$3.8M. Revenue was up 23.3% from 2023-12-31 to 2024-12-31. ETON currently screens at market cap $797.9M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ETON currently screens at market cap $797.9M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ETON and ROP stock pages for the full models.
Not investment advice.